造影剂肾病影响因素logistics回归分析  

Logistics Regression Analysis of Influencing Factors of Contrast Associated Nephropathy

作　　者：李亮 王帅 孙庆春 王爽 

机构地区：[1]吉化集团公司总医院肾内科,吉林132021 [2]吉化集团公司总医院心血管内科,吉林132021 [3]吉化集团公司总医院二院介入科,吉林132021

出　　处：《临床误诊误治》2017年第6期74-76,共3页Clinical Misdiagnosis & Mistherapy

基　　金：吉林省科技发展计划项目(200805119)

摘　　要：目的分析经皮冠状动脉介入治疗(percutaneous coronary intervention,PCI)患者发生造影剂肾病(contrastassoci ated nephropathy,CAN)的原因及影响因素。方法收集我院2014年1月—2016年1月行PCI的415例临床资料,根据是否发生CAN将其分为CAN组(n=75)与非CAN组(n=340)。分析发生CAN的影响因素。结果本研究CAN发生率为18.1%。年龄、造影剂使用量及急诊PCI、慢性肾脏病、心肌梗死、低血压、2型糖尿病及心力衰竭与CAN的发生具有明显相关性。结论 PCI患者发生CAN与多种因素有关,对危重患者行PCI时,应从多方面考虑,以减少CAN的发生。Objective To analyze causes and influencing factors of contrast associated nephropathy （CAN） in pa- tients with percutaneous coronary intervention （PCI）. Methods Clinical data of 415 patients undergoing PCI during January 2014 and January 2016 was collected, and the patients were divided into CAN group （n = 75） and non-CAN group （n = 340） depending on whether or not having CAN. Influencing factors of CAN pathogenesy were analyzed. Results The incidence rate of CAN was 18.1% in this group. Age, dosage of using contrast agent, PCI in emergency department, chronic kidney disease, myocardial infarction, hypotension, type 2 diabetes mellitus and heart failure were correlated to pathogenesy of CAN. Conclusion Pathogenesy CAN is correlated to many factors in patients undergoing PCI, and therefore when critical patients will undergo PCI, clinicians should take more consideration in order to reduce incidence rate of CAN.

关 键 词：造影剂肾病 经皮冠状动脉介入治疗 影响因素分析 

分 类 号：R541.4[医药卫生—心血管疾病] R692[医药卫生—内科学]